Management to Host Conference Call Today at 5 p.m. ET CHICAGO, Nov. 10, 2022 /PRNewswire/ - KFS Kingsway Financial Services Inc. ("Kingsway" or the "Company") today announced its operating results for the three and nine months ended …
-First patient dosed with JANX007 in first-in-human Phase 1 clinical trial in prostate cancer patients- -Interim clinical update from Phase 1 trial of JANX007 expected in 2H 2023- -IND application for EGFR-TRACTr (JANX008) remains on-track to be submitted …
CAHmelia-203 Approaching 50% Enrollment; CAHmelia-204 Recently Surpassed 25% Enrollment Appointment of Saba Sile, M.D., as Vice President of Clinical Development Spruce Biosciences, Inc. SPRB, a late-stage biopharmaceutical company focused on developing …
First Quarter Fiscal 2023 Revenue Increased 184% to a Record $17.8 Million First Quarter Fiscal 2023 Gross Profit Increased 195% to $3.9 Million Management to Host Conference Call Today at 4:30 p.m. Eastern Time Flux Power Holdings, Inc. FLUX, a developer …
NEW YORK, Nov. 10, 2022 /PRNewswire/ -- Integral Ad Science Holding Corp. IAS, a global leader in digital media quality, announced today the appointment of Tania Secor as Chief Financial Officer (CFO), effective December 5, 2022. Secor will lead the global …
˗ RELYVRIO™ (sodium phenylbutyrate and taurursodiol) approved for the treatment of ALS in adults and now commercially available in the U.S., representing second product launch for Amylyx worldwide ˗ Commercial launch of ALBRIOZA™ (sodium phenylbutyrate and …
Presented positive complete results from the MISSION Phase 2 trial evaluating zetomipzomib in patients with lupus nephritis at ASN's Kidney Week 2022 Annual Meeting Received FDA clearance of IND for zetomipzomib for the treatment of autoimmune …
HeartBeam AIMI™ Platform Technology for use in Diagnosing Heart Attacks Submitted to FDA for Clearance Company on Track for Initial FDA Submission of HeartBeam AIMIGo™, the Telehealth Solution, in Q4 2022 AIMIGo Technology Receives Two Additional Patents …
EndeavorRx®, the world's first FDA-authorized video game treatment, saw quarter over quarter growth in number of prescribers and volume of prescriptions; Initiated commercial launch in Q3 Raised more than $164 million in gross proceeds with business …
KORU Medical Systems KRMD ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that …
BELLUS Health Inc. BLUBLU ("BELLUS Health" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough ("RCC") and other cough hypersensitivity …
CARLSBAD, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") AFIB, an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported …
Las Vegas, Nev. – Traffic on CC-215 will be shifted into a new configuration near U.S. 95 as construction in the Centennial Bowl interchange continues. The shift requires an overnight closure of CC-215 in both directions Tuesday night into Wednesday …
VALENCIA, Calif. and MELBOURNE, Australia, Nov. 10, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. RCELAVH)) (the "Company"), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous …
BALTIMORE, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Adams Natural Resources Fund, Inc. (NYSE: PEO) declared today a year-end distribution of $1.33 per share. The total distributions by the Fund for 2022 will be $1.63, including the distributions totaling $0.30 …
PITTSBURGH, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Duolingo, Inc. DUOL, the world's leading mobile learning platform, announced results for the third quarter ended September 30, 2022 in a shareholder letter that is posted at investors.duolingo.com. " …
Novel monoclonal antibody combination candidate (NVD200) on track to advance into clinical trials in Q1 2023 $419 million in cash, cash equivalents and marketable securities expected to support operating runway into Q2 2024 Conference call scheduled for …
ORLANDO, Fla., Nov. 10, 2022 (GLOBE NEWSWIRE) -- IZEA Worldwide, Inc. IZEA, the premier provider of influencer marketing technology, data, and services for the world's leading brands, reported its financial and operational results for the third quarter …
GMV and total revenue YoY growth reached 29% and 22%, respectively Gross profit increased 37% YoY, representing a margin expansion of 750 bps YoY VTEX VTEX, the enterprise digital commerce platform for premier brands and retailers, the leader in …
Revenue for the first nine months of 2022 increased 26% to $57.7 million versus the same period in 2021 of $45.6 million DFD-29 Phase 3 studies are 75% enrolled to date Top-line data from the Phase 3 clinical program evaluating DFD-29 for the treatment of …
